EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Role of AI in Drug Discovery in Africa

Kelly Chibale

Daedalus · 10.06.2026 · 155 (1-2) · 277-288

DOI: 10.1162/daed.a.987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Daedalus, online erschienen am 10.06.2026. Verfasst von Kelly Chibale. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The proliferation of artificial intelligence presents Africa's drug discovery landscape with a transformative opportunity to accelerate research and development (R&D) to address the continent's heavy disease burden. The integration of AI in drug discovery processes will help researchers by streamlining research pipelines and improving the design of clinical trials so that historically underserved populations can access cost-effective medication tailored to their needs. While challenges include AI skepticism, scarcity of data, and concerns about job losses, sustained advocacy and capacity-building can help to allay these concerns and facilitate widespread buy-in and adoption of AI tools across the continent. At a time of diminished funding for R&D globally, AI-assisted drug discovery-with its potential to alter fundamentally the pace and cost of R&D-should help Africa move toward a sustainable and innovative pharmaceutical paradigm led by Africans, out of Africa, for the global community.

Zitieren

APA

Chibale, K. (2026). The Role of AI in Drug Discovery in Africa. Daedalus, 155(1-2), 277-288. https://doi.org/10.1162/daed.a.987

Vancouver

Chibale K. The Role of AI in Drug Discovery in Africa. Daedalus. 2026;155(1-2):277-288. doi:10.1162/daed.a.987

BibTeX
@article{Chibale2026,
  author = {Chibale, Kelly},
  title = {The Role of AI in Drug Discovery in Africa},
  journal = {Daedalus},
  year = {2026},
  volume = {155},
  number = {1-2},
  pages = {277--288},
  doi = {10.1162/daed.a.987}
}
Kostenlos starten →